Compass Financial Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
Other funds holding BBC
Compass Financial Management's BBC Position: Q3 2026 in Review
Compass Financial Management reduced its Virtus Biotech Clinical Trials ETF (BBC) stake by 91% in Q3 2026, selling an estimated $25.4K and leaving 49 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1434.
Compass Financial Management first reported a position in BBC in Q2 2026 and has held it in 2 quarters since. The position peaked at $28.5K in Q2 2026. 13 funds tracked by Wall St. Rank hold BBC as of Q3 2026.
- Compass Financial Management held 49 shares of Virtus Biotech Clinical Trials ETF worth $2.27K as of Q3 2026.
- Compass Financial Management sold 496 Virtus Biotech Clinical Trials ETF shares in Q3 2026, an estimated $25.4K.
- Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Compass Financial Management's portfolio in Q3 2026, its #1434 holding.
- Compass Financial Management first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2026 and has held it in 2 quarters since.
- Compass Financial Management's Virtus Biotech Clinical Trials ETF position peaked at $28.5K in Q2 2026.
- 13 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2026.
Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.